Condition
Menstrual Cycle Disorder
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07286136Not ApplicableCompletedPrimary
Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial
NCT06585475Not ApplicableCompleted
Investigation of the Effectiveness of Structured Education According to Premenstrual Syndrome Symptom Map
NCT04281446Not ApplicableCompletedPrimary
Physical Performance of Women at Different Stages of the Menstrual Cycle, and Photobiomodulation Therapy
Showing all 3 trials